Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 462

1.

Estrogen receptor promoter methylation predicts survival in low-grade ovarian carcinoma patients.

Kirn V, Shi R, Heublein S, Knabl J, Guenthner-Biller M, Andergassen U, Fridrich C, Malter W, Harder J, Friese K, Mayr D, Jeschke U.

J Cancer Res Clin Oncol. 2014 Jun 8. [Epub ahead of print]

PMID:
24908329
[PubMed - as supplied by publisher]
2.

Circulating tumor cells predict survival in early average-to-high risk breast cancer patients.

Rack B, Schindlbeck C, Jückstock J, Andergassen U, Hepp P, Zwingers T, Friedl TW, Lorenz R, Tesch H, Fasching PA, Fehm T, Schneeweiss A, Lichtenegger W, Beckmann MW, Friese K, Pantel K, Janni W; SUCCESS Study Group.

J Natl Cancer Inst. 2014 May 15;106(5). pii: dju066. doi: 10.1093/jnci/dju066.

PMID:
24832787
[PubMed - indexed for MEDLINE]
Free Article
3.

Evaluation of two different analytical methods for circulating tumor cell detection in peripheral blood of patients with primary breast cancer.

Jaeger BA, Jueckstock J, Andergassen U, Salmen J, Schochter F, Fink V, Alunni-Fabbroni M, Rezai M, Beck T, Beckmann MW, Friese K, Friedl TW, Janni W, Rack B.

Biomed Res Int. 2014;2014:491459. doi: 10.1155/2014/491459. Epub 2014 Apr 8.

PMID:
24800234
[PubMed - in process]
Free PMC Article
4.

Shaping the System - The DRG Evaluation Project of the German Society for Gynaecology and Obstetrics (Deutsche Gesellschaft für Gynäkologie und Geburtshilfe, DGGG).

Fiori W, Renner SP, Siam K, Babapirali J, Roeder N, Dausch E, Hildebrandt T, Hillemanns P, Nehmzow M, Zygmunt M, Piroth D, Schem C, Schwenzer T, Friese K, Wallwiener D, Beckmann MW.

Geburtshilfe Frauenheilkd. 2013 Aug;73(8):776-782.

PMID:
24771931
[PubMed]
Free PMC Article
5.

Detection of circulating tumour cells on mRNA levels with established breast cancer cell lines.

Zebisch M, Kölbl AC, Andergassen U, Hutter S, Neugebauer J, Engelstädter V, Günthner-Biller M, Jeschke U, Friese K, Rack B.

Biomed Rep. 2013 Mar;1(2):231-234. Epub 2012 Dec 5.

PMID:
24648925
[PubMed]
Free PMC Article
6.

Glycodelin A - a famous lipocalin and its role in breast cancer.

Kölbl AC, Jeschke U, Dian D, Friese K, Andergassen U.

Anticancer Res. 2014 Mar;34(3):1079-85. Review.

PMID:
24596346
[PubMed - indexed for MEDLINE]
7.

ESR1 promoter methylation in squamous cell cervical cancer.

Kirn V, Zaharieva I, Heublein S, Thangarajah F, Friese K, Mayr D, Jeschke U.

Anticancer Res. 2014 Feb;34(2):723-7.

PMID:
24511005
[PubMed - indexed for MEDLINE]
8.

Malnutrition and clinical outcome in gynecologic patients.

Hertlein L, Kirschenhofer A, Fürst S, Beer D, Göß C, Lenhard M, Friese K, Burges A, Rittler P.

Eur J Obstet Gynecol Reprod Biol. 2014 Mar;174:137-40. doi: 10.1016/j.ejogrb.2013.12.028. Epub 2014 Jan 14.

PMID:
24485666
[PubMed - in process]
9.

Validation of an anatomical coordinate system for clinical evaluation of the knee joint in upright and closed MRI.

Olender G, Hurschler C, Fleischer B, Friese KI, Sukau A, Gutberlet M, Becher C.

Ann Biomed Eng. 2014 May;42(5):1133-42. doi: 10.1007/s10439-014-0980-1. Epub 2014 Jan 28.

PMID:
24468976
[PubMed - in process]
10.

13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013).

Untch M, Gerber B, Harbeck N, Jackisch C, Marschner N, Möbus V, von Minckwitz G, Loibl S, Beckmann MW, Blohmer JU, Costa SD, Decker T, Diel I, Dimpfl T, Eiermann W, Fehm T, Friese K, Jänicke F, Janni W, Jonat W, Kiechle M, Köhler U, Lück HJ, Maass N, Possinger K, Rody A, Scharl A, Schneeweiss A, Thomssen C, Wallwiener D, Welt A.

Breast Care (Basel). 2013 Jun;8(3):221-9. doi: 10.1159/000351692.

PMID:
24415975
[PubMed]
Free PMC Article
11.

Detection and characterisation of disseminated tumour cells in bone marrow of breast cancer patients by immunostaining of Her-2 and MUC-1 in combination with Thomsen-Friedenreich (CD176).

Andergassen U, Kölbl AC, Zebisch M, Heublein S, Hutter S, Ilmer M, Schindlbeck C, Friese K, Jeschke U.

Histol Histopathol. 2014 Jul;29(7):913-23. Epub 2014 Jan 8.

PMID:
24399516
[PubMed - in process]
12.

Prophylactic mastectomy with immediate reconstruction combined with simultaneous laparoscopic salpingo-oophorectomy via a transmammary route: a novel surgical approach to female BRCA-mutation carriers.

Perabò M, Fink V, Günthner-Biller M, von Bodungen V, Friese K, Dian D.

Arch Gynecol Obstet. 2014 Jun;289(6):1325-30. doi: 10.1007/s00404-013-3133-0. Epub 2014 Jan 4.

PMID:
24389920
[PubMed - in process]
13.

Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer.

Lenhard M, Heublein S, Kunert-Keil C, Vrekoussis T, Lomba I, Ditsch N, Mayr D, Friese K, Jeschke U.

BMC Cancer. 2013 Dec 30;13:616. doi: 10.1186/1471-2407-13-616.

PMID:
24377825
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Significance of the tumor protease cathepsin D for the biology of breast cancer.

Dian D, Heublein S, Wiest I, Barthell L, Friese K, Jeschke U.

Histol Histopathol. 2014 Apr;29(4):433-8. Epub 2013 Nov 22.

PMID:
24265119
[PubMed - in process]
15.

Four countries, four ways of discussing low-risk pregnancy and normal delivery: in France, Germany, The Netherlands, and the United Kingdom.

Schott S, van der Avoort I, Descamps P, Richmond D, Adams T, Oei G, Hédon B, Friese K.

Arch Gynecol Obstet. 2014 Feb;289(2):451-6. doi: 10.1007/s00404-013-3083-6. Epub 2013 Nov 20.

PMID:
24253339
[PubMed - in process]
16.

Detection of Circulating Tumour Cells from Blood of Breast Cancer Patients via RT-qPCR.

Andergassen U, Kölbl AC, Hutter S, Friese K, Jeschke U.

Cancers (Basel). 2013 Sep 25;5(4):1212-20. doi: 10.3390/cancers5041212.

PMID:
24202442
[PubMed]
Free PMC Article
17.

Peroxisome proliferator-activated receptor-gamma (PPARγ) is down regulated in trophoblast cells of gestational diabetes mellitus (GDM) and in trophoblast tumour cells BeWo in vitro after stimulation with PPARγ agonists.

Knabl J, Hüttenbrenner R, Hutter S, Günthner-Biller M, Vrekoussis T, Karl K, Friese K, Kainer F, Jeschke U.

J Perinat Med. 2014 Mar;42(2):179-87. doi: 10.1515/jpm-2013-0039.

PMID:
24190593
[PubMed - in process]
18.

Sexuality in German urogynecological patients and healthy controls: is there a difference with respect to the diagnosis?

Schoenfeld M, Fuermetz A, Muenster M, Ennemoser S, von Bodungen V, Friese K, Jundt K.

Eur J Obstet Gynecol Reprod Biol. 2013 Oct;170(2):567-70. doi: 10.1016/j.ejogrb.2013.08.002. Epub 2013 Aug 11.

PMID:
23988220
[PubMed - indexed for MEDLINE]
19.

The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients.

Heublein S, Mayr D, Vrekoussis T, Friese K, Hofmann SS, Jeschke U, Lenhard M.

PLoS One. 2013 Aug 9;8(8):e71791. doi: 10.1371/journal.pone.0071791. eCollection 2013.

PMID:
23951246
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Nelfinavir and bortezomib inhibit mTOR activity via ATF4-mediated sestrin-2 regulation.

Brüning A, Rahmeh M, Friese K.

Mol Oncol. 2013 Dec;7(6):1012-8. doi: 10.1016/j.molonc.2013.07.010. Epub 2013 Jul 20.

PMID:
23916134
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk